Grants / Archive / National Institutes of Health / 2021

National Institutes of Health grant notices posted in 2021, now closed

• RFA-DA-22-047: HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01 Clinical Trial Optional)
  Posted December 29, 2021, closed March 10, 2022
• RFA-DA-22-048: HEAL Initiative: Pilot and Feasibility Trials to Improve Prevention and Treatment Service Delivery for Polysubstance Use (R34 Clinical Trial Optional)
  Posted December 29, 2021, closed March 10, 2022
• RFA-DA-22-034: HEAL Initiative: Planning Grants for Efficacy or Effectiveness Trials of Recovery Support Services for Individuals Treated with Medications for Opioid Use Disorder (R34 Clinical Trial Optional)
  Posted December 29, 2021, closed March 10, 2022
• RFA-DA-22-042: HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders: Coordination Center (R24 Clinical Trial Optional)
  Posted December 29, 2021, closed March 10, 2022
• RFA-DA-22-046: HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders (R01 Clinical Trial Optional)
  Posted December 29, 2021, closed March 10, 2022
• RFA-DA-22-043: HEAL Initiative: Research Networks for the Study of Recovery Support Services for Persons Treated with Medications for Opioid Use Disorder (R24 Clinical Trial Optional)
  Posted December 29, 2021, closed March 10, 2022
• RFA-AG-23-009: Lipids in Brain Aging and Alzheimer's Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed)
  Posted December 28, 2021, closed June 14, 2022
• RFA-MH-22-135: Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
  Posted December 23, 2021, closed October 15, 2022
• RFA-MH-22-136: Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
  Posted December 23, 2021, closed October 15, 2022
• PAR-22-077: NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional)
  Posted December 22, 2021, closed February 15, 2024
• PAR-22-093: Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
  Posted December 22, 2021, closed November 12, 2024
• PAR-22-094: Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)
  Posted December 22, 2021, closed November 12, 2024
• PAS-22-096: Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
  Posted December 22, 2021, closed December 10, 2024
• RFA-AI-21-079: Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
  Posted December 22, 2021, closed June 3, 2022
• RFA-AG-23-003: Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)
  Posted December 20, 2021, closed July 1, 2022
• RFA-DA-22-044: HEAL Initiative: Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R01- Clinical Trial Not Allowed)
  Posted December 20, 2021, closed March 10, 2022
• RFA-DA-22-045: HEAL Initiative: Exploratory Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R21- Clinical Trial Not Allowed)
  Posted December 20, 2021, closed March 10, 2022
• RFA-OD-22-002: Center for Rapid Surveillance of Tobacco (CRST) to Assess Changes in Use Behaviors, Product Marketing, and the Marketplace (U01 Clinical Trial Not Allowed)
  Posted December 15, 2021, closed May 18, 2022
• RFA-RM-22-002: SPARC VNS Endpoints from Standardized Parameters (VESPA) (U54 Clinical Trial Required)
  Posted December 14, 2021, closed April 1, 2022
• RFA-AT-22-006: NIH-DOD-VA Pain Management Collaboratory Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required)
  Posted December 14, 2021, closed March 15, 2022
• PAR-21-358: Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional)
  Posted December 13, 2021, closed December 13, 2024
• RFA-EY-21-004: Ocular Surface Innervation from Cell Types to Circuit Functions (U01 Clinical Trial Not Allowed)
  Posted December 10, 2021, closed March 7, 2022
• RFA-EB-21-001: Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
  Posted December 10, 2021, closed May 2, 2025
• RFA-EY-21-003: BRAIN Initiative-Related Research Education: Short Courses (R25 Clinical Trial Not Allowed)
  Posted December 10, 2021, closed February 15, 2024
• RFA-MD-22-002: Research Centers in Minority Institutions (RCMI) (U54 Clinical Trials Optional)
  Posted December 10, 2021, closed January 26, 2022
• RFA-RM-22-007: Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)
  Posted December 9, 2021, closed February 18, 2022
• RFA-HG-22-001: Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
  Posted December 6, 2021, closed February 27, 2024
• PAR-21-356: Limited Competition: Research Resource for the National Swine Resource and Research Center (U42 Clinical Trial Not Allowed)
  Posted December 3, 2021, closed September 25, 2022
• RFA-DK-21-030: New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed)
  Posted December 3, 2021, closed March 20, 2023
• PAS-22-074: Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional)
  Posted December 1, 2021, closed May 7, 2025
• PAR-22-068: Continuation or Revision of NIDCR Clinical Trial Implementation Cooperative Agreement (UH3 Clinical Trial Required)
  Posted December 1, 2021, closed January 8, 2025
• RFA-NS-22-011: BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)
  Posted December 1, 2021, closed April 17, 2023
• RFA-HD-23-020: Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center (UM2 Clinical Trial Optional)
  Posted December 1, 2021, closed March 31, 2022
• RFA-HD-23-021: Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
  Posted December 1, 2021, closed March 31, 2022
• PAR-22-069: High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
  Posted November 30, 2021, closed October 30, 2024
• RFA-HD-23-010: Child Health Research Career Development Award (CHRCDA) Program (K12 Clinical Trial Not Allowed)
  Posted November 29, 2021, closed March 30, 2022
• PAR-22-065: NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed)
  Posted November 29, 2021, closed June 14, 2024
• RFA-AG-22-030: Resource Networks for Protein Polymorphisms in Alzheimers Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed)
  Posted November 29, 2021, closed January 10, 2022
• RFA-DK-21-035: Coordinating Unit for the National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD) (U24 - Clinical Trial Not Allowed)
  Posted November 29, 2021, closed March 8, 2022
• PAR-22-031: Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)
  Posted November 29, 2021, closed January 7, 2025
• RFA-DK-21-027: National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD) (U2C - Clinical Trial Not Allowed)
  Posted November 29, 2021, closed March 8, 2022
• RFA-DK-21-032: Fostering Research With Additional Resources and Development (FORWARD) Urology Centers (P20 Clinical Trial Not Allowed)
  Posted November 29, 2021, closed March 24, 2022
• PAR-22-071: Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)
  Posted November 23, 2021, closed November 17, 2024
• RFA-DK-21-034: Analysis, Technology, Leadership, Administration and Science (ATLAS) Center (U24 Clinical Trial Not Allowed)
  Posted November 23, 2021, closed March 24, 2022
• RFA-CA-22-001: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
  Posted November 23, 2021, closed September 22, 2022
• RFA-CA-22-002: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
  Posted November 23, 2021, closed September 22, 2022
• PAR-22-072: Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)
  Posted November 20, 2021, closed May 7, 2024
• PAR-21-342: Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)
  Posted November 19, 2021, closed December 13, 2023
• RFA-NS-22-015: Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Network Clinical Center (Hub) (U24 Clinical Trial Not Allowed)
  Posted November 19, 2021, closed January 18, 2022
• RFA-NS-22-014: Limited Competition: Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Clinical Coordinating Center (CCC) (U24 Clinical Trial Not Allowed)
  Posted November 19, 2021, closed January 18, 2022
• PAR-22-067: Basic Neurodevelopmental Biology of Circuits and Behavior (R21 Clinical Trial Not Allowed)
  Posted November 19, 2021, closed January 7, 2025
• PAR-22-073: Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)
  Posted November 19, 2021, closed February 2, 2024
• PAR-21-343: Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
  Posted November 19, 2021, closed April 18, 2024
• RFA-NS-22-013: Limited Competition: Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Data Coordinating Center (DCC) (U24 Clinical Trial Not Allowed)
  Posted November 19, 2021, closed January 18, 2022
• RFA-EY-21-002: Age-related Macular Degeneration (AMD) Integrative Biology Initiative: Discovery of AMD Pathobiology using Patient-Derived Induced Pluripotent Stem Cell (iPSC)-derived Retinal Pigment Epithelium (RPE) (U01 Clinical Trial Not Allowed)
  Posted November 17, 2021, closed February 17, 2022
• RFA-RM-22-006: Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed)
  Posted November 17, 2021, closed June 10, 2022
• PAR-22-032: Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed)
  Posted November 17, 2021, closed January 7, 2025
• PAR-22-055: Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed)
  Posted November 16, 2021, closed March 22, 2023
• PAR-22-070: NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
  Posted November 16, 2021, closed January 19, 2022
• RFA-AT-22-003: HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)
  Posted November 16, 2021, closed February 11, 2022
• RFA-AG-23-004: Understanding Place-Based Health Inequalities in Mid-Life (R01 Clinical Trial Not Allowed)
  Posted November 16, 2021, closed March 3, 2022
• PAR-22-064: Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional)
  Posted November 16, 2021, closed January 7, 2025
• RFA-HL-23-008: NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
  Posted November 16, 2021, closed February 28, 2024
• RFA-DA-22-036: NIH HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional)
  Posted November 16, 2021, closed March 2, 2022
• PAR-22-066: Basic Neurodevelopmental Biology of Circuits and Behavior (R01 Clinical Trial Not Allowed)
  Posted November 16, 2021, closed January 7, 2025
• RFA-HL-23-009: NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
  Posted November 16, 2021, closed February 28, 2024
• PAR-22-047: Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
  Posted November 15, 2021, closed November 5, 2024
• RFA-MH-22-150: Using Just-in-Time Adaptive Interventions to Optimize Established Adolescent Mental Health Treatments (R61/R33 Clinical Trial Required)
  Posted November 15, 2021, closed January 13, 2023
• PAR-22-030: Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
  Posted November 9, 2021, closed October 11, 2024
• PAR-21-354: Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional)
  Posted November 9, 2021, closed November 16, 2024
• PAR-21-355: Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
  Posted November 9, 2021, closed November 16, 2024
• PAR-21-353: Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
  Posted November 9, 2021, closed November 5, 2024
• PAR-22-028: Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)
  Posted November 9, 2021, closed December 17, 2024
• RFA-CA-21-061: NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
  Posted November 5, 2021, closed February 28, 2022
• RFA-AG-22-026: Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)
  Posted November 4, 2021, closed February 3, 2022
• PAR-22-062: Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)
  Posted November 3, 2021, closed January 7, 2025
• PAR-22-061: Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed)
  Posted November 3, 2021, closed January 7, 2025
• PAR-22-059: Prodromal Synaptic and Circuit Changes that Contribute to AD/ADRD Onset and Progression (R01 Clinical Trial Not Allowed)
  Posted November 3, 2021, closed February 5, 2022
• PAR-22-056: Limited Competition: Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed)
  Posted November 3, 2021, closed September 25, 2022
• RFA-CA-22-003: Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
  Posted November 3, 2021, closed September 22, 2022
• RFA-CA-22-004: Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
  Posted November 3, 2021, closed September 22, 2022
• RFA-CA-21-062: NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
  Posted November 3, 2021, closed February 28, 2022
• RFA-CA-21-060: NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
  Posted November 3, 2021, closed February 28, 2022
• PAR-22-053: Clinical Trial Readiness for Functional Neurological Disorders (U01 Clinical Trial Optional)
  Posted November 2, 2021, closed November 5, 2024
• RFA-AI-21-078: RePORT International Coordinating Center (RICC) (U01 Clinical Trial Not Allowed)
  Posted November 2, 2021, closed March 17, 2022
• PAR-22-054: Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
  Posted November 1, 2021, closed February 23, 2022
• RFA-AT-22-005: HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required)
  Posted October 29, 2021, closed December 15, 2021
• RFA-AT-22-004: HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional)
  Posted October 29, 2021, closed December 15, 2021
• RFA-HD-22-017: Home and Community-Based Physical Activity Interventions to Improve the Health of Wheelchair Users (R01 Clinical Trial Required)
  Posted October 29, 2021, closed March 30, 2022
• RFA-RM-22-005: Cellular Senescence Network: Technology Development and Application in Murine Systems (UG3/UH3 Clinical Trial Not Allowed)
  Posted October 28, 2021, closed January 19, 2022
• RFA-AG-23-002: Cell-Specific Impact of Liquid-Liquid Phase Separation in Aging and AD/ADRD (R21 Clinical Trial Not Allowed)
  Posted October 28, 2021, closed March 3, 2022
• RFA-RM-22-004: Cellular Senescence Network: Technology Development and Application in Human Systems (UG3/UH3 Clinical Trial Not Allowed)
  Posted October 28, 2021, closed January 18, 2022
• RFA-HD-22-023: Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional)
  Posted October 27, 2021, closed March 30, 2022
• RFA-AT-22-002: Limited Competition: NIH Health Care Systems Research Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed)
  Posted October 27, 2021, closed December 15, 2021
• RFA-RM-22-003: Cellular Senescence Network: Murine Tissue Mapping Centers (U54 - Clinical Trial Not Allowed)
  Posted October 27, 2021, closed January 19, 2022
• RFA-CA-21-045: Coordinating Center for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (U24 Clinical Trial Required)
  Posted October 26, 2021, closed December 28, 2021
• RFA-CA-21-047: Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)
  Posted October 26, 2021, closed December 28, 2021
• RFA-AG-23-001: Understanding the Role of Bilingualism in Cognitive Reserve/Resilience in Aging and AD/ADRD (R01 Clinical Trial Optional)
  Posted October 26, 2021, closed March 3, 2022
• RFA-CA-21-046: Research Bases for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)
  Posted October 26, 2021, closed December 28, 2021
• RFA-HD-23-005: Promoting Reproductive Health for Adolescents and Adults with Disabilities (R01 Clinical Trial Optional)
  Posted October 26, 2021, closed March 30, 2022
• PAR-22-049: Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
  Posted October 21, 2021, closed September 13, 2024
• RFA-MH-22-106: Expanding Differentiated Care Approaches for Adolescents Living with HIV (R34 Clinical Trial Optional)
  Posted October 20, 2021, closed January 6, 2022
• PAR-21-347: Clinical Research Education and Career Development (CRECD) Program (R25-Independent Clinical Trial Not Allowed)
  Posted October 19, 2021, closed December 15, 2021
• RFA-CA-21-063: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Optional)
  Posted October 19, 2021, closed December 10, 2021
• RFA-MH-22-105: Expanding Differentiated Care Approaches for Adolescents Living with HIV (R01 Clinical Trial Optional)
  Posted October 18, 2021, closed January 6, 2022
• RFA-MH-22-125: Enhanced Interpersonal Focused Strategies for Suicide Prevention Interventions (R34 Clinical Trial Required)
  Posted October 18, 2021, closed February 18, 2022
• RFA-AI-21-075: Identification and Characterization of Persistence Mechanisms of Select Protozoan Pathogens (R01 Clinical Trial Not Allowed)
  Posted October 18, 2021, closed February 8, 2022
• RFA-NS-21-025: NIH Blueprint for Neuroscience Research Short Courses in Neurotherapeutics Development (R25 Clinical Trial Not Allowed)
  Posted October 15, 2021, closed December 9, 2021
• RFA-AI-21-070: Advancing Group A Streptococcus Vaccine Discovery (R01 Clinical Trial Not Allowed)
  Posted October 15, 2021, closed February 18, 2022
• RFA-AT-22-001: NIH Health Care Systems Research Collaboratory - Pragmatic and Implementation Trials of Embedded Interventions (UG3/UH3, Clinical Trials Optional)
  Posted October 14, 2021, closed June 17, 2022
• RFA-HD-22-022: Pelvic Floor Disorders Network (U24 Clinical Trial Required)
  Posted October 13, 2021, closed December 6, 2021
• PAR-22-048: Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
  Posted October 13, 2021, closed March 11, 2022
• RFA-HD-22-021: Pelvic Floor Disorders Network (UG1 Clinical Trial Required)
  Posted October 13, 2021, closed December 6, 2021
• RFA-DK-21-029: Diabetes Research Centers (P30 Clinical Trial Optional)
  Posted October 13, 2021, closed March 8, 2022
• PAR-21-321: Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
  Posted October 12, 2021, closed January 7, 2026
• PAR-22-034: NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)
  Posted October 12, 2021, closed July 12, 2024
• PAR-21-341: Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
  Posted October 12, 2021, closed October 8, 2024
• PAR-22-039: Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
  Posted October 12, 2021, closed January 7, 2025
• PAR-22-038: Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
  Posted October 12, 2021, closed January 7, 2025
• PAR-22-040: NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)
  Posted October 12, 2021, closed July 12, 2024
• RFA-NS-22-002: HEAL Initiative: Advancing Health Equity in Pain Management (R61/R33 Clinical Trial Required)
  Posted October 8, 2021, closed December 9, 2021
• RFA-MH-22-120: Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional)
  Posted October 8, 2021, closed February 21, 2023
• PAR-22-025: NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
  Posted October 7, 2021, closed February 7, 2025
• RFA-GM-22-001: IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed)
  Posted October 7, 2021, closed January 5, 2022
• RFA-RM-21-024: SPARC Human Open Research Neural Engineering Technologies (HORNET) Initiative (U41 Clinical Trial Not Allowed)
  Posted October 6, 2021, closed January 12, 2022
• RFA-ES-21-007: Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional)
  Posted October 6, 2021, closed February 1, 2024
• PAR-21-312: Genomic Curriculum Development for Medical Students (R25 Clinical Trial Not Allowed)
  Posted October 5, 2021, closed January 25, 2024
• PAR-21-349: Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required)
  Posted October 5, 2021, closed June 21, 2024
• PAR-21-350: Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed)
  Posted October 5, 2021, closed June 21, 2024
• PAR-21-352: Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trial Required)
  Posted October 5, 2021, closed September 7, 2024
• RFA-DK-21-025: Pediatric Obesity Discovery Science Research to Improve Understanding of Risk and Causal Mechanisms for Obesity in Early Life (R01 Clinical Trial Optional)
  Posted October 4, 2021, closed March 8, 2022
• RFA-NS-21-019: Neurosurgeon Research Career Development Program (NRCDP) (K12 Independent Clinical Trial Not Allowed)
  Posted October 4, 2021, closed December 15, 2021
• RFA-HL-22-013: HEAL initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression Without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development) (UG3/UH3 Clinical Trials Not Allowed)
  Posted September 30, 2021, closed December 3, 2021
• PAR-22-037: Role of Astrocytes in Degeneration of the Neurovascular Unit in AD/ADRDs (R01 Clinical Trial Not Allowed)
  Posted September 30, 2021, closed February 4, 2022
• RFA-OD-21-010: Advancing Gender Inclusive Excellence (AGIE) Coordinating Center (U54 Clinical Trial Not Allowed)
  Posted September 30, 2021, closed November 30, 2021
• PAR-21-346: Limited Competition: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)
  Posted September 29, 2021, closed November 17, 2021
• PAR-21-344: Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)
  Posted September 28, 2021, closed December 20, 2022
• PAR-21-351: NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed)
  Posted September 28, 2021, closed February 24, 2024
• PAR-22-021: NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed)
  Posted September 27, 2021, closed March 22, 2023
• RFA-AI-21-065: Systems Biology for Infectious Diseases (U19 Clinical Trial Not Allowed)
  Posted September 27, 2021, closed January 14, 2022
• PAR-21-348: The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional)
  Posted September 27, 2021, closed December 15, 2023
• RFA-MH-22-100: Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries (R34 Clinical Trial Optional)
  Posted September 24, 2021, closed December 9, 2021
• RFA-OD-21-007: INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed)
  Posted September 24, 2021, closed November 3, 2022
• PAR-21-326: Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed)
  Posted September 24, 2021, closed December 1, 2021
• RFA-AG-22-029: Limited Competition: Renewal of the Caenorhabditis Intervention Testing Program (U01 Clinical Trial Not Allowed)
  Posted September 23, 2021, closed October 27, 2021
• PAR-21-337: Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
  Posted September 22, 2021, closed September 13, 2024
• PAR-21-329: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
  Posted September 22, 2021, closed November 5, 2024
• PAR-21-338: Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
  Posted September 22, 2021, closed September 13, 2024
• RFA-AG-22-028: Limited Competition:Caenorhabditis Intervention Testing Program Data Coordinating Center (U24 Clinical Trial Not Allowed)
  Posted September 21, 2021, closed October 27, 2021
• RFA-CA-21-059: The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
  Posted September 21, 2021, closed November 18, 2021
• PAR-21-333: NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)
  Posted September 20, 2021, closed November 4, 2021
• RFA-AI-21-060: SUNBEAM - Analysis and Bioinformatics Center (ABC) (UM1 Clinical Trial Not Allowed)
  Posted September 20, 2021, closed February 15, 2022
• RFA-AI-21-068: Development of Microbiome-Related Approaches for Diagnosis/Mitigation/Treatment of Radiation Injuries (U01 Clinical Trial Not Allowed)
  Posted September 20, 2021, closed February 9, 2022
• PAR-22-035: Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
  Posted September 20, 2021, closed January 7, 2023
• PAR-22-036: Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
  Posted September 20, 2021, closed January 13, 2023
• PAR-21-336: Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
  Posted September 17, 2021, closed September 13, 2024
• PAR-21-339: Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
  Posted September 17, 2021, closed September 13, 2024
• PAR-21-340: Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)
  Posted September 17, 2021, closed November 7, 2023
• PAR-21-335: Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)
  Posted September 16, 2021, closed June 11, 2024
• PAR-21-334: Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
  Posted September 16, 2021, closed June 11, 2024
• PAR-21-325: Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed)
  Posted September 15, 2021, closed May 7, 2022
• RFA-RM-21-026: Tissue Mapping Centers for the Human BioMolecular Atlas Program (U54 Clinical Trial Not Allowed)
  Posted September 14, 2021, closed November 19, 2021
• PAR-21-319: Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
  Posted September 13, 2021, closed December 11, 2023
• PAR-21-311: Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
  Posted September 13, 2021, closed December 11, 2023
• PAR-21-302: NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)
  Posted September 10, 2021, closed December 2, 2024
• PAR-21-327: Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
  Posted September 10, 2021, closed November 12, 2024
• PAR-21-328: Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
  Posted September 10, 2021, closed November 12, 2024
• PAR-21-300: NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed)
  Posted September 10, 2021, closed December 2, 2024
• PAS-21-270: AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
  Posted September 10, 2021, closed January 7, 2025
• PAR-21-301: NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)
  Posted September 10, 2021, closed December 2, 2024
• PAR-21-299: NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required)
  Posted September 10, 2021, closed December 2, 2024
• RFA-RM-21-027: The Human BioMolecular Atlas Program (HuBMAP) Demonstration Project (U01 Clinical Trial Not Allowed)
  Posted September 10, 2021, closed November 19, 2021
• RFA-NS-22-017: Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed)
  Posted September 10, 2021, closed November 12, 2021
• PA-21-345: Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
  Posted September 10, 2021, closed September 9, 2024
• RFA-HL-22-004: An Intergenerational Precision Medicine Research Program for the Study of Factor VIII Immunogenicity in Severe Hemophilia A: Hemophilia A Analytical Cohort Research Program (UG3/UH3 Clinical Trial Not Allowed)
  Posted September 9, 2021, closed October 19, 2021
• RFA-DA-22-028: Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R01 - Clinical Trial Optional)
  Posted September 8, 2021, closed February 9, 2022
• RFA-DA-22-040: High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
  Posted September 8, 2021, closed August 2, 2024
• PAR-21-330: Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
  Posted September 8, 2021, closed October 11, 2024
• RFA-DA-22-039: Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R21 - Clinical Trial Optional)
  Posted September 8, 2021, closed February 9, 2022
• PAR-21-251: Emerging Global Leader Award (K43 Independent Clinical Trial Required)
  Posted September 8, 2021, closed December 11, 2023
• PAR-21-252: Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
  Posted September 8, 2021, closed October 14, 2024
• RFA-NS-22-009: Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and Health Equity, Pragmatic Clinical Trials (U01 Clinical Trial Required)
  Posted September 8, 2021, closed November 10, 2021
• PAR-21-331: Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
  Posted September 3, 2021, closed September 5, 2024
• PAR-21-332: Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
  Posted September 3, 2021, closed September 5, 2024
• RFA-DK-21-026: Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)
  Posted September 3, 2021, closed June 8, 2023
• PAR-22-029: Longitudinal Single Cell Characterization of ADRD Postmortem Tissue (R01 Clinical Trial Not Allowed)
  Posted September 2, 2021, closed October 22, 2021
• PAR-21-322: Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
  Posted September 2, 2021, closed September 7, 2024
• PAR-21-323: Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
  Posted September 2, 2021, closed September 7, 2024
• PAR-22-022: NINDS Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
  Posted September 2, 2021, closed July 12, 2024
• RFA-DK-21-502: Limited Competition for the Data Coordinating Center (DCC) for the NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) (U24 Clinical Trial Optional)
  Posted September 2, 2021, closed December 21, 2021
• PAR-21-324: Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed)
  Posted September 2, 2021, closed September 7, 2024
• PAR-22-027: Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
  Posted September 2, 2021, closed January 13, 2025
• RFA-CA-21-020: National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)
  Posted September 1, 2021, closed September 28, 2023
• RFA-CA-21-057: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT U01 Clinical Trial Not Allowed)
  Posted September 1, 2021, closed September 22, 2021
• PAR-21-317: NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
  Posted September 1, 2021, closed December 1, 2024
• RFA-CA-21-058: Data, Evaluation and Coordinating Center for: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) (U24 Clinical Trial Not Allowed)
  Posted September 1, 2021, closed November 19, 2021
• PAR-21-320: NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
  Posted September 1, 2021, closed November 15, 2024
• RFA-AA-21-015: Collaborative Partnership between Research Centers in Minority Institutions (RCMI) and Alcohol Research Centers (U54 Clinical Trial Optional)
  Posted September 1, 2021, closed December 15, 2021
• RFA-DK-21-022: NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genetic Research Centers (GRCs) (U01 Clinical Trial Optional)
  Posted September 1, 2021, closed December 21, 2021
• RFA-DK-21-019: National Program for the Career Development Of Physician Scientists in Diabetes Research (Diabetes - Docs) (K12 Clinical Trial Optional)
  Posted August 31, 2021, closed November 18, 2021
• PAR-21-295: NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
  Posted August 31, 2021, closed November 12, 2024
• PAR-21-298: Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R41/R42 Clinical Trial Not Allowed)
  Posted August 31, 2021, closed December 9, 2023
• RFA-HG-21-036: Limited Competition: Knockout Mouse Production and Phenotyping Project (UM1) Clinical Trial Not Allowed
  Posted August 31, 2021, closed November 1, 2021
• RFA-HG-21-037: Limited Competition: Knockout Mouse Phenotyping Project Data Coordination Center and Database (UM1 Clinical Trial Not Allowed)
  Posted August 31, 2021, closed November 1, 2021
• RFA-CA-21-054: Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed)
  Posted August 31, 2021, closed November 2, 2021
• RFA-CA-21-055: Translational and Basic Science Research in Early Lesions (TBEL) Coordinating and Data Management Center (U24 Clinical Trial Not Allowed)
  Posted August 31, 2021, closed November 2, 2021
• PAR-21-296: NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)
  Posted August 31, 2021, closed November 12, 2024
• RFA-DK-21-024: Pediatric Centers of Excellence in Nephrology (P50 Clinical Trial Optional)
  Posted August 31, 2021, closed November 18, 2021
• PAR-21-297: Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R43/R44 Clinical Trial Not Allowed)
  Posted August 31, 2021, closed December 9, 2023
• RFA-NS-22-016: HEAL Initiative: Interdisciplinary Teams to Elucidate the Mechanisms of Device-Based Pain Relief (RM1 Clinical Trial Optional)
  Posted August 31, 2021, closed November 3, 2021
• PAR-21-279: Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
  Posted August 26, 2021, closed September 29, 2023
• PAR-21-278: Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)
  Posted August 26, 2021, closed September 29, 2023
• RFA-CA-21-056: Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)
  Posted August 25, 2021, closed December 15, 2021
• RFA-HD-22-005: Learning Disabilities Innovation Hubs (P20 Clinical Trial Optional)
  Posted August 25, 2021, closed November 30, 2021
• RFA-HD-22-009: Impact of Technology and Digital Media (TDM) Exposure/Usage on Child and Adolescent Development (P01 Clinical Trial Optional)
  Posted August 25, 2021, closed November 29, 2021
• RFA-RM-21-014: Limited Competition: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed)
  Posted August 24, 2021, closed October 20, 2021
• RFA-HD-22-008: Autism Centers of Excellence: Centers (P50 Clinical Trial Optional)
  Posted August 23, 2021, closed November 9, 2021
• RFA-HD-22-007: Autism Centers of Excellence: Networks (R01 Clinical Trial Optional)
  Posted August 23, 2021, closed November 9, 2021
• PAR-21-313: Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
  Posted August 20, 2021, closed January 7, 2025
• PAR-21-314: Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed)
  Posted August 20, 2021, closed October 20, 2021
• PAR-21-315: Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
  Posted August 20, 2021, closed September 27, 2024
• PAR-21-306: NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
  Posted August 20, 2021, closed October 31, 2023
• RFA-AA-21-017: HIV Prevention and Alcohol (R34 Clinical Trials Optional)
  Posted August 20, 2021, closed December 16, 2021
• RFA-AA-21-016: HIV Prevention and Alcohol (R01 Clinical Trials Optional)
  Posted August 20, 2021, closed December 16, 2021
• PAR-21-282: Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional)
  Posted August 20, 2021, closed September 28, 2024
• PAR-22-026: Selectively Target Technology Development to Understand How Changes or Dysfunction at the Capillary, Arterioles, and Small Lymphatic Vessels Level Can Have Long-term Impact on AD/ADRD (R01 Clinical Trial Not Allowed)
  Posted August 19, 2021, closed November 8, 2021
• RFA-MH-21-251: Deciphering Immune-CNS interactions in HIV utilizing in-vitro and in-vivo model systems (R21 Clinical Trial Not Allowed)
  Posted August 19, 2021, closed December 7, 2021
• RFA-MH-21-250: Deciphering Immune-CNS interactions in people living with HIV on Anti-Retroviral therapy (R01 Clinical Trial Optional)
  Posted August 19, 2021, closed December 7, 2021
• RFA-MD-22-001: Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required)
  Posted August 18, 2021, closed January 14, 2022
• PAR-21-273: Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Basic Experimental Studies with Humans Required (BESH))
  Posted August 17, 2021, closed July 24, 2024
• PAR-21-277: Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)
  Posted August 17, 2021, closed November 15, 2023
• PAR-21-316: Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)
  Posted August 17, 2021, closed January 6, 2023
• RFA-DK-21-503: Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
  Posted August 17, 2021, closed November 30, 2021
• RFA-RM-21-013: Limited Competition: Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)
  Posted August 17, 2021, closed October 29, 2021
• PAR-21-271: Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
  Posted August 17, 2021, closed July 23, 2024
• PAR-21-272: Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required)
  Posted August 17, 2021, closed July 24, 2024
• RFA-DA-22-022: Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional)
  Posted August 12, 2021, closed November 11, 2021
• RFA-AI-21-058: American Women: Assessing Risk Epidemiologically (AWARE) (R01 Clinical Trial Optional)
  Posted August 12, 2021, closed December 9, 2021
• RFA-ES-21-009: Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed)
  Posted August 12, 2021, closed November 10, 2021
• RFA-DE-22-005: Feasibility Studies that Explore Healthy and Diseased Temporomandibular Joints (TMJ) using Single Cell Multi-Omic Analyses (UH2/UH3 Clinical Trial Not Allowed)
  Posted August 12, 2021, closed November 10, 2021
• RFA-DK-21-017: High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 - Clinical Trial Not Allowed)
  Posted August 12, 2021, closed March 3, 2022
• RFA-ES-21-008: Innovative Approaches for Improving Environmental Health Literacy (R43/R44 Clinical Trial Not Allowed)
  Posted August 12, 2021, closed November 10, 2021
• PAR-21-305: Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
  Posted August 11, 2021, closed January 9, 2025
• PAR-21-307: Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required)
  Posted August 11, 2021, closed February 13, 2024
• PAR-21-308: Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 Clinical Trial Required)
  Posted August 11, 2021, closed February 13, 2024
• PAR-22-024: Clinical and Biological Measures of TBI-related Dementia Including Chronic Traumatic Encephalopathy (R01 Clinical Trial Not Allowed)
  Posted August 10, 2021, closed November 10, 2021
• RFA-NS-21-009: Creating an Educational Nexus for Training in Experimental Rigor (CENTER) (UC2 Clinical Trial Not Allowed)
  Posted August 10, 2021, closed October 21, 2021
• RFA-MD-21-003: Resource Center for Tribal Epidemiological Centers (RC-TEC) (U24 Clinical Trial Not Allowed)
  Posted August 9, 2021, closed November 30, 2021
• RFA-NS-22-001: Biomarkers for the Lewy Body Dementias (U01 Clinical Trial Not Allowed)
  Posted August 6, 2021, closed November 22, 2021
• RFA-HG-21-031: Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U24 Clinical trials not allowed)
  Posted August 6, 2021, closed November 1, 2021
• PAR-22-023: Multi-Disciplinary Collaborations to Understand Mechanisms of Systemic Immune Signaling and Inflammation in ADRD and its Progression (R01 Clinical Trial Not Allowed)
  Posted August 6, 2021, closed October 22, 2021
• RFA-HG-21-030: Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U01 Clinical trials not allowed)
  Posted August 6, 2021, closed November 1, 2021
• RFA-HG-21-029: Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase 1: Data Production Research and Development Centers (UM1)(Clinical trials not allowed)
  Posted August 6, 2021, closed November 1, 2021
• RFA-HG-21-041: New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)
  Posted August 5, 2021, closed February 22, 2024
• PAR-21-304: Brazil Regional Prospective Observational Research in Tuberculosis (RePORT) (U01 Clinical Trial Not Allowed)
  Posted August 5, 2021, closed December 8, 2021
• PAR-21-303: Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
  Posted August 4, 2021, closed December 9, 2022
• RFA-DK-21-010: Cardiovascular Biorepository for Type 1 Diabetes (U24 Clinical Trial Not Allowed)
  Posted August 4, 2021, closed October 20, 2021
• RFA-HG-21-033: Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed)
  Posted August 3, 2021, closed January 12, 2022
• PAR-21-292: Pilot Studies to Test the Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34 Clinical Trial Required)
  Posted August 3, 2021, closed January 13, 2023
• PAR-21-283: Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required )
  Posted August 3, 2021, closed January 13, 2023
• PAR-21-284: Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 Clinical Trial Optional)
  Posted August 3, 2021, closed January 6, 2023
• PAR-21-291: Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01 Clinical Trial Required)
  Posted August 3, 2021, closed January 6, 2023
• RFA-CA-21-053: Coordinating and Data Management Center for Acquired Resistance to Therapy Network (ARTNet; U24 Clinical Trial Not Allowed)
  Posted August 3, 2021, closed November 1, 2021
• RFA-CA-21-052: Acquired Resistance to Therapy Network (ARTNet; U54 Clinical Trial Not Allowed)
  Posted August 3, 2021, closed November 1, 2021
• PAR-21-310: Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional)
  Posted August 2, 2021, closed January 8, 2025
• PAR-21-309: Imaging - Science Track Award for Research Transition (I/START) (R03- Basic Experimental Studies with Humans Required)
  Posted August 2, 2021, closed January 8, 2025
• RFA-NS-22-006: Leveraging Existing Data Resources for Computational Model and Tool Development to Discover Novel Candidate Mechanisms and Biomarkers for ADRD (R01 Clinical Trial Not Allowed)
  Posted August 2, 2021, closed October 26, 2021
• PAR-21-293: Clinical and Translational Science Award (UM1 Clinical Trial Optional)
  Posted July 30, 2021, closed September 13, 2024
• RFA-DA-22-018: Advancing Validated Drug Targets for Substance Use Disorders (R41/R42 - Clinical Trial Not Allowed)
  Posted July 29, 2021, closed February 18, 2022
• RFA-DA-22-023: Advancing Validated Drug Targets for Substance Use Disorders (R43/R44 - Clinical Trial Not Allowed)
  Posted July 29, 2021, closed February 18, 2022
• PAR-21-254: Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
  Posted July 29, 2021, closed January 7, 2025
• RFA-CA-21-049: Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed)
  Posted July 29, 2021, closed November 12, 2021
• PAR-21-256: NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)
  Posted July 29, 2021, closed July 13, 2023
• PAR-21-255: Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
  Posted July 29, 2021, closed January 7, 2025
• PAR-21-288: Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
  Posted July 28, 2021, closed January 13, 2023
• PAR-21-289: Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
  Posted July 28, 2021, closed January 6, 2023
• RFA-DK-21-018: Pilot and Feasibility Studies to Improve Technology Adoption and Reduce Health Disparities in Type 1 Diabetes Mellitus (R01 Clinical Trial Required)
  Posted July 28, 2021, closed March 3, 2022
• RFA-CA-21-048: Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed)
  Posted July 28, 2021, closed October 19, 2022
• RFA-CA-21-050: Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)
  Posted July 27, 2021, closed September 27, 2021
• RFA-MH-21-235: BRAIN Initiative Cell Atlas Network (BICAN): Comprehensive Center on Human and Non-human Primate Brain Cell Atlases (UM1 Clinical Trial Not Allowed)
  Posted July 27, 2021, closed November 9, 2021
• RFA-MH-21-236: BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (U01 Clinical Trial Not Allowed)
  Posted July 27, 2021, closed November 9, 2021
• RFA-CA-21-051: Coordinating Center for Canine Cancer Immunotherapy Network (K9CIN; U24 Clinical Trial Not Allowed)
  Posted July 27, 2021, closed September 27, 2021
• RFA-MH-21-237: BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) (U24 Clinical Trial Not Allowed)
  Posted July 27, 2021, closed November 9, 2021
• RFA-NS-21-033: Materials to Enhance Training in Experimental Rigor (METER) (UE5 Clinical Trial Not Allowed)
  Posted July 27, 2021, closed October 10, 2023
• RFA-CA-21-041: Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed)
  Posted July 26, 2021, closed November 1, 2021
• RFA-CA-21-042: Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (PSRC CDMC) (U24 Clinical Trial Not Allowed)
  Posted July 26, 2021, closed November 1, 2021
• PAR-21-286: NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
  Posted July 23, 2021, closed November 1, 2021
• RFA-AG-22-023: Limited Competition: Data Management and Coordinating Center (DMCC) and a Collaborative Research Space for Translational Research on Exceptional Longevity (U24 Clinical Trial Not Allowed)
  Posted July 22, 2021, closed October 28, 2021
• PAR-21-290: Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
  Posted July 22, 2021, closed January 7, 2025
• PAR-21-294: Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
  Posted July 22, 2021, closed November 5, 2024
• RFA-DA-22-033: Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)
  Posted July 22, 2021, closed February 17, 2022
• PAR-21-285: NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
  Posted July 21, 2021, closed November 1, 2021
• PAR-21-287: Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional)
  Posted July 19, 2021, closed January 7, 2025
• PAR-21-276: Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)
  Posted July 16, 2021, closed July 15, 2022
• PAR-21-267: NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
  Posted July 16, 2021, closed November 26, 2023
• PAR-21-258: NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
  Posted July 16, 2021, closed September 7, 2023
• RFA-AG-22-015: Aging Research in Animals (ARIA): Promoting Rigorous Research on Behavioral and Social Processes (R61/R33 Clinical Trial Not Allowed)
  Posted July 15, 2021, closed October 20, 2021
• RFA-AG-22-024: Primary Care-Based Screening and Intervention Development for Prevention of Abuse in Older and Vulnerable Adults in the Context of Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Required)
  Posted July 15, 2021, closed October 20, 2021
• PAR-21-265: NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)
  Posted July 15, 2021, closed April 5, 2024
• PAR-21-266: NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
  Posted July 15, 2021, closed November 27, 2023
• RFA-CA-21-038: Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)
  Posted July 15, 2021, closed October 7, 2021
• RFA-CA-21-039: Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24 Clinical Trial Not Allowed)
  Posted July 15, 2021, closed October 7, 2021
• RFA-AG-22-021: Elucidating the Roles of Transposable Elements in AD/ADRD and Aging (R01 Clinical Trial Not Allowed)
  Posted July 14, 2021, closed November 2, 2021
• RFA-DK-21-013: Continuation of The Collaborative Islet Transplantation Registry (U01 Clinical Trial Not Allowed)
  Posted July 14, 2021, closed October 20, 2021
• RFA-DK-21-002: Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)
  Posted July 14, 2021, closed March 3, 2022
• RFA-MH-21-205: BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
  Posted July 14, 2021, closed September 1, 2023
• RFA-DK-21-003: Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Biostatistics Research Center (U01 Clinical Trial Not Allowed)
  Posted July 14, 2021, closed March 3, 2022
• RFA-HL-22-014: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
  Posted July 13, 2021, closed October 8, 2021
• PAR-21-274: Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed)
  Posted July 12, 2021, closed October 6, 2022
• RFA-LM-21-002: Network of the National Library of Medicine All of Us Program Center (U24) (Clinical Trial Optional)
  Posted July 12, 2021, closed September 17, 2021
• RFA-RM-21-025: NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)
  Posted July 12, 2021, closed September 24, 2021
• PAR-21-247: Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)
  Posted July 12, 2021, closed June 15, 2023
• RFA-HG-21-001: Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed)
  Posted July 9, 2021, closed December 1, 2022
• RFA-HG-21-002: Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed)
  Posted July 9, 2021, closed December 1, 2022
• PAR-21-281: Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed)
  Posted July 9, 2021, closed May 7, 2023
• PAR-21-280: Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans)
  Posted July 9, 2021, closed May 7, 2023
• PAR-21-248: Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed)
  Posted July 9, 2021, closed May 7, 2024
• RFA-AI-21-050: Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed)
  Posted July 9, 2021, closed October 22, 2021
• PA-21-259: PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
  Posted July 8, 2021, closed April 5, 2022
• PA-21-262: PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
  Posted July 8, 2021, closed April 5, 2022
• PA-21-261: PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
  Posted July 8, 2021, closed April 5, 2022
• PA-21-260: PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
  Posted July 8, 2021, closed April 5, 2022
• RFA-DA-23-001: Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes In The Context of Substance Use Disorders (R61/R33 Clinical Trials Optional)
  Posted July 8, 2021, closed August 11, 2022
• PAR-21-239: NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials)
  Posted July 8, 2021, closed December 5, 2024
• PAR-21-264: Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional)
  Posted July 7, 2021, closed September 25, 2023
• PAR-21-263: Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional)
  Posted July 7, 2021, closed September 25, 2023
• RFA-AI-21-041: Innate Immune Memory Impacting HIV Acquisition and/or Control (R21 Clinical Trial Not Allowed)
  Posted July 7, 2021, closed December 6, 2021
• RFA-DA-22-031: HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed)
  Posted July 6, 2021, closed October 19, 2021
• RFA-DA-22-032: HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed)
  Posted July 6, 2021, closed October 19, 2021
• RFA-AG-22-022: Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed)
  Posted July 6, 2021, closed October 28, 2021
• RFA-AG-22-027: Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
  Posted July 6, 2021, closed November 2, 2021
• RFA-CA-21-021: Metabolic Dysregulation and Cancer Risk Program, Research Grants: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional)
  Posted July 6, 2021, closed October 6, 2021
• RFA-CA-21-022: Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancer Research (U24 Clinical Trial Not Allowed)
  Posted July 6, 2021, closed October 6, 2021
• RFA-DA-22-020: Growing Great Ideas: Research Education Course in Product Development and Entrepreneurship for Life Science Researchers (UE5 Clinical Trial Not Allowed)
  Posted July 6, 2021, closed November 18, 2021
• RFA-DK-21-014: Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions Knowledgebase Management Center (U24 Clinical Trial Not Allowed)
  Posted July 6, 2021, closed October 20, 2021
• PAR-21-246: HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)
  Posted July 6, 2021, closed December 8, 2022
• PAR-21-253: Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)
  Posted July 6, 2021, closed October 19, 2023
• RFA-HG-21-025: New Investigators to Promote Workforce Diversity in Genomics and other Health-Related Research (R01 Clinical Trial Optional)
  Posted June 30, 2021, closed July 29, 2021
• PA-21-268: Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
  Posted June 30, 2021, closed June 30, 2024
• RFA-DE-22-003: Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R01 Clinical Trial Not Allowed)
  Posted June 29, 2021, closed November 18, 2021
• RFA-DE-22-004: Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R21 Clinical Trial Not Allowed)
  Posted June 28, 2021, closed November 18, 2021
• PAR-21-269: Research on Interventions that Promote the Careers of Individuals in the Biomedical Research Enterprise (R01 Clinical Trial Not Allowed)
  Posted June 28, 2021, closed October 13, 2023
• RFA-DA-22-029: Exploratory Studies to Investigate the Mechanisms of Interrelationship between Sleep and Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans Required)
  Posted June 28, 2021, closed October 14, 2021
• PAR-21-204: NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed)
  Posted June 28, 2021, closed September 7, 2024
• RFA-DK-21-021: Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)
  Posted June 25, 2021, closed October 7, 2022
• PAR-21-249: India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed)
  Posted June 25, 2021, closed November 8, 2023
• RFA-MH-21-241: Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R34 Clinical Trial Required)
  Posted June 25, 2021, closed November 9, 2021
• RFA-CA-21-026: Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional)
  Posted June 25, 2021, closed October 8, 2021
• RFA-CA-21-027: Coordinating Center for the Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed)
  Posted June 25, 2021, closed October 8, 2021
• RFA-DC-22-001: NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional)
  Posted June 25, 2021, closed June 20, 2024
• RFA-ES-21-006: CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)
  Posted June 25, 2021, closed September 20, 2023
• RFA-MH-21-240: Prevention of Perinatal Depression: Improving Intervention Delivery for At-Risk Individuals (R01 Clinical Trial Required)
  Posted June 25, 2021, closed November 9, 2021
• PAR-21-275: The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
  Posted June 25, 2021, closed September 7, 2024
• RFA-CA-21-040: Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
  Posted June 24, 2021, closed November 1, 2021
• RFA-AG-22-025: Data Enhancements and Analyses to Clarify the Relationship between Education and Cognitive Function (including AD/ADRD) (R01 Clinical Trial Not Allowed)
  Posted June 23, 2021, closed October 20, 2021
• RFA-DA-22-003: Elucidating the Effects of ART on Neuronal Function in the Context of SUD and HIV (R01 - Clinical Trials Not Allowed)
  Posted June 23, 2021, closed February 2, 2022
• PAR-21-250: Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Optional)
  Posted June 22, 2021, closed September 7, 2024
• RFA-DA-22-011: Large Scale Mapping and/or Molecular Profiling of Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed)
  Posted June 21, 2021, closed October 15, 2021
• RFA-DA-22-009: Organoid Modeling of Neural Stimulants and HIV Comorbidity of Human Brain (R01- Clinical Trial Optional)
  Posted June 17, 2021, closed November 17, 2021
• RFA-HL-22-012: Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)
  Posted June 17, 2021, closed February 23, 2024
• RFA-AG-22-018: Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed)
  Posted June 17, 2021, closed October 28, 2021
• RFA-AG-22-017: Role of Adaptive Immunity in Etiology of Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional)
  Posted June 16, 2021, closed October 28, 2021
• RFA-DA-22-017: PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional)
  Posted June 16, 2021, closed November 12, 2021
• RFA-AI-20-069: Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional)
  Posted June 15, 2021, closed October 13, 2021
• PAR-21-240: Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
  Posted June 14, 2021, closed December 21, 2023
• PAR-21-241: NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
  Posted June 14, 2021, closed December 21, 2023
• PAR-21-242: Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
  Posted June 14, 2021, closed March 11, 2024
• PAR-21-243: Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
  Posted June 14, 2021, closed March 11, 2024
• PAS-21-245: Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
  Posted June 14, 2021, closed September 7, 2024
• PAR-21-244: NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)
  Posted June 10, 2021, closed August 12, 2024
• RFA-AG-22-014: NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional)
  Posted June 10, 2021, closed October 26, 2021
• RFA-AG-22-007: NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional)
  Posted June 10, 2021, closed October 26, 2021
• RFA-AG-22-004: NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed)
  Posted June 10, 2021, closed September 29, 2021
• RFA-AG-22-019: High Resolution Mapping of Biomolecules in Brain Cells in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed)
  Posted June 10, 2021, closed October 28, 2021
• RFA-AI-21-046: Promoting Bunyavirales Basic Science Research (R01 Clinical Trial Not Allowed)
  Posted June 10, 2021, closed October 22, 2021
• RFA-AG-22-003: NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Clinical Trial Not Allowed)
  Posted June 10, 2021, closed October 4, 2021
• RFA-NS-21-029: HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed)
  Posted June 8, 2021, closed October 10, 2023
• RFA-RM-21-023: Integration, Dissemination, and Evaluation (BRIDGE) Center for the NIH Bridge to Artificial Intelligence (Bridge2AI) Program (U54 Clinical Trial Not Allowed)
  Posted June 8, 2021, closed August 20, 2021
• RFA-NS-21-026: BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
  Posted June 8, 2021, closed February 8, 2023
• RFA-NS-21-027: BRAIN Initiative: Optimization of Transformative Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
  Posted June 8, 2021, closed February 8, 2023
• RFA-DA-22-016: Exploratory Studies to Investigate the Mechanisms of Interrelationship Between Sleep and Substance Use Disorders (R61/R33 Clinical Trials Not Allowed)
  Posted June 4, 2021, closed October 14, 2021
• RFA-AA-21-007: Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01 Clinical Trials Optional)
  Posted June 4, 2021, closed August 18, 2021
• RFA-AA-21-009: Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24 Clinical Trials Optional)
  Posted June 4, 2021, closed August 18, 2021
• RFA-RM-21-017: NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
  Posted June 4, 2021, closed September 1, 2021
• RFA-AA-21-008: Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24 Clinical Trials Optional)
  Posted June 4, 2021, closed August 18, 2021
• RFA-DK-21-016: Characterization of Islet-derived Extracellular Vesicles for Improved Detection, Monitoring, Classification, and Treatment of Type 1 Diabetes (R01 Clinical Trial Not Allowed)
  Posted June 3, 2021, closed November 3, 2021
• RFA-HG-21-026: Non-Human Primate Developmental Genotype-Tissue Expression (NHP dGTEx) Project (U24 Clinical Trials Not Allowed)
  Posted June 3, 2021, closed August 2, 2021
• PAR-21-138: Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional)
  Posted June 3, 2021, closed December 1, 2024
• PAR-21-257: Shared Personal Protective Equipment (PPE) Resources (S10 Clinical Trial Not Allowed)
  Posted June 3, 2021, closed May 24, 2022
• RFA-AA-21-012: Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Diagnostic-Telemedicine Resource (U24 Clinical Trial Not Allowed)
  Posted June 2, 2021, closed August 16, 2021
• RFA-AA-21-013: Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Data Coordination Resource (U24 Clinical Trial Not Allowed)
  Posted June 2, 2021, closed August 16, 2021
• RFA-AA-21-014: Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Developmental Project (UH2 Clinical Trial Optional)
  Posted June 2, 2021, closed August 16, 2021
• RFA-AA-21-010: Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Project (U01 Clinical Trial optional)
  Posted June 2, 2021, closed August 16, 2021
• RFA-AA-21-011: Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Administrative Resource (U24) (Clinical Trial Not Allowed)
  Posted June 2, 2021, closed August 16, 2021
• RFA-CA-21-033: The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)
  Posted June 1, 2021, closed September 9, 2021
• RFA-CA-21-035: The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)
  Posted June 1, 2021, closed September 9, 2021
• RFA-CA-21-034: The Early Detection Research Network: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed)
  Posted June 1, 2021, closed September 9, 2021
• PAR-21-220: NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed)
  Posted May 28, 2021, closed July 12, 2024
• PAR-21-217: NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed)
  Posted May 28, 2021, closed December 8, 2024
• PAR-21-218: NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31)
  Posted May 28, 2021, closed December 8, 2024
• PA-21-232: Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional)
  Posted May 26, 2021, closed September 7, 2024
• RFA-HL-22-011: Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
  Posted May 26, 2021, closed May 7, 2024
• RFA-HL-22-010: Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)
  Posted May 25, 2021, closed May 7, 2024
• RFA-DA-22-005: Mechanistic studies on the impact of social inequality on the substance use trajectory (R21 - Clinical Trial Not Allowed)
  Posted May 24, 2021, closed October 14, 2021
• RFA-DA-22-007: Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed)
  Posted May 24, 2021, closed October 14, 2021
• RFA-DA-22-024: Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Basic Experimental Studies with Humans Required)
  Posted May 24, 2021, closed October 14, 2021
• RFA-MH-21-225: Adapting Immunotherapy and Gene Editing Based Strategies for Targeting HIV Reservoirs in the CNS: Potential Benefits and Risks (R01 Clinical Trial Optional)
  Posted May 24, 2021, closed August 27, 2021
• PAR-21-230: Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)
  Posted May 24, 2021, closed March 11, 2022
• RFA-DA-22-030: Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R21 - Basic Experimental Studies with Humans Required)
  Posted May 24, 2021, closed October 14, 2021
• RFA-MH-21-226: Adapting Immunotherapy and Gene Editing Based Strategies for Targeting HIV Reservoirs in the CNS: Potential Benefits and Risks (R21 Clinical Trial Optional)
  Posted May 24, 2021, closed August 27, 2021
• RFA-DA-22-012: Assessing the Effects of Cannabinoids on HIV-Associated Persistent Inflammation (R01 Clinical Trial Optional)
  Posted May 24, 2021, closed August 5, 2021
• RFA-RM-21-016: NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
  Posted May 20, 2021, closed August 20, 2021
• RFA-DK-21-012: Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)
  Posted May 19, 2021, closed October 7, 2022
• PAR-21-154: Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
  Posted May 19, 2021, closed May 7, 2024
• PAR-21-155: Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
  Posted May 19, 2021, closed May 7, 2024
• PAR-21-237: NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)
  Posted May 19, 2021, closed January 9, 2025
• RFA-TW-21-004: Launching Future Leaders in Global Health (LAUNCH) Research Training Program (D43 Clinical Trial Optional)
  Posted May 19, 2021, closed August 20, 2021
• PA-21-180: Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)
  Posted May 11, 2021, closed January 7, 2025
• RFA-ES-21-005: SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
  Posted May 11, 2021, closed July 30, 2021
• RFA-AI-21-016: Emerging Science and Technology in Transplantation (U01 Clinical Trial Not Allowed)
  Posted May 11, 2021, closed September 3, 2021
• RFA-HL-22-001: T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)
  Posted May 11, 2021, closed February 28, 2024
• PA-21-235: NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed)
  Posted May 10, 2021, closed January 7, 2025
• PA-21-205: Development and Testing of Novel Interventions to improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required)
  Posted May 10, 2021, closed January 7, 2025
• PAR-21-168: Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)
  Posted May 10, 2021, closed May 7, 2024
• PA-21-219: Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional)
  Posted May 10, 2021, closed January 7, 2025
• RFA-AI-21-039: Consortium for Innovative HIV/AIDS Vaccine and Cure Research (UM1 Clinical Trial Not Allowed)
  Posted May 7, 2021, closed August 4, 2021
• RFA-NS-21-023: BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
  Posted May 7, 2021, closed February 20, 2024
• PAR-21-228: NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed)
  Posted May 7, 2021, closed September 22, 2023
• PAR-21-236: NINDS Exploratory Clinical Trials (U01 - Clinical Trial Required)
  Posted May 7, 2021, closed May 7, 2022
• RFA-NS-21-024: BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
  Posted May 7, 2021, closed February 20, 2024
• RFA-DK-21-007: Standardization of C-Peptide and HbA1C Measurements Program (U01 Clinical Trial Not Allowed)
  Posted May 7, 2021, closed October 20, 2021
• RFA-NS-21-020: Research Program Award (R35 Clinical Trial Optional)
  Posted May 6, 2021, closed July 13, 2021
• RFA-DK-21-011: Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed)
  Posted May 6, 2021, closed October 7, 2022
• RFA-HL-23-005: NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
  Posted May 5, 2021, closed April 25, 2024
• RFA-HD-22-020: Human Milk as a Biological System (R01 Clinical Trial Optional)
  Posted May 5, 2021, closed November 29, 2021
• PAR-21-223: NeuroNEXT Clinical Trials (U01 Clinical Trial Optional)
  Posted May 5, 2021, closed March 5, 2024
• PAR-21-224: NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
  Posted May 5, 2021, closed September 5, 2024
• RFA-HL-23-004: NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
  Posted May 5, 2021, closed April 25, 2024
• PAR-21-229: Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed)
  Posted May 5, 2021, closed October 29, 2024
• PAR-21-238: Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)
  Posted May 4, 2021, closed January 6, 2022
• RFA-CA-21-032: Coordinating Center for Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U24 Clinical Trial Not Allowed)
  Posted May 3, 2021, closed July 14, 2021
• RFA-CA-21-031: Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U01 Clinical Trial Required)
  Posted May 3, 2021, closed July 14, 2021
• PAR-21-225: Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)
  Posted April 30, 2021, closed January 5, 2025
• PAR-21-226: Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)
  Posted April 30, 2021, closed January 6, 2025
• RFA-DE-22-002: Addressing Social Determinants of Health to Eliminate Oral Health Disparities (UG3/UH3 Clinical Trials Optional)
  Posted April 29, 2021, closed July 26, 2021
• RFA-DK-21-023: NIDDK Short-Term Research Experience Program to Unlock Potential (STEP-UP) (R25 Clinical Trial Not Allowed)
  Posted April 29, 2021, closed September 1, 2021
• RFA-NS-21-021: Translational Neural Devices (UG3/UH3 - Clinical Trial Optional)
  Posted April 28, 2021, closed February 20, 2024
• RFA-NS-21-022: Translational Neural Devices (U44 Clinical Trial Optional)
  Posted April 28, 2021, closed December 20, 2022
• RFA-DA-22-001: Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional)
  Posted April 27, 2021, closed August 13, 2021
• RFA-MH-21-175: BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
  Posted April 27, 2021, closed May 8, 2023
• PAR-21-227: Resource Center for the Support for Research Excellence (SuRE) Program (U24 - Clinical Trial Not Allowed)
  Posted April 27, 2021, closed September 24, 2021
• RFA-AI-21-017: Systems Approach to Understand Mechanisms of Heterogeneous Response to Influenza (R01 Clinical Trial Not Allowed)
  Posted April 27, 2021, closed September 8, 2021
• RFA-RM-21-018: NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
  Posted April 26, 2021, closed September 3, 2021
• PAR-21-233: Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
  Posted April 23, 2021, closed August 19, 2024
• PAR-21-234: NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)
  Posted April 23, 2021, closed September 7, 2024
• RFA-DK-20-026: Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed)
  Posted April 22, 2021, closed September 23, 2021
• RFA-DK-20-028: Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)
  Posted April 22, 2021, closed October 25, 2021
• RFA-DK-20-029: Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)
  Posted April 22, 2021, closed September 23, 2021
• RFA-DK-20-027: Kidney Precision Medicine Project Kidney Tissue Atlas Coordinating Center (U01 Clinical Trial Not Allowed)
  Posted April 22, 2021, closed September 23, 2021
• PA-21-221: NICHD Small Research Grant Program (R03 Clinical Trial Required)
  Posted April 21, 2021, closed January 7, 2025
• RFA-NS-21-012: NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed)
  Posted April 21, 2021, closed December 15, 2023
• PA-21-231: NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
  Posted April 21, 2021, closed January 7, 2025
• RFA-AI-21-030: Centers for HIV Structural Biology (U54 Clinical Trial Not Allowed)
  Posted April 20, 2021, closed October 13, 2021
• RFA-MH-21-230: Pilot Effectiveness Trials of Interventions for Preschoolers with ADHD (R34 Clinical Trial Required)
  Posted April 19, 2021, closed March 1, 2022
• RFA-HD-22-004: Developmental Mechanisms of Human Structural Birth Defects (P01 Clinical Trial Not Allowed)
  Posted April 19, 2021, closed July 29, 2021
• PAR-21-209: NIH Countermeasures Against Chemical Threats (CounterACT) Early-stage Investigator Research Award (R21 Clinical Trial Not Allowed)
  Posted April 19, 2021, closed July 27, 2021
• RFA-MH-21-187: Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R01 Clinical Trial Optional)
  Posted April 16, 2021, closed June 29, 2021
• RFA-MH-21-188: Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R34 Clinical Trial Optional)
  Posted April 16, 2021, closed June 29, 2021
• RFA-OD-21-006: Building Interdisciplinary Research Careers in Women's Health Program (BIRCWH) (K12 Clinical Trial Optional)
  Posted April 16, 2021, closed June 11, 2021
• PAS-21-215: Identification of Positive Valence System Related Targets for Novel Suicide Prevention Approaches (R21 Clinical Trial Optional)
  Posted April 16, 2021, closed October 16, 2021
• RFA-MH-21-185: Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Black Children and Adolescents (R01 Clinical Trial Optional)
  Posted April 16, 2021, closed June 29, 2021
• RFA-MH-21-186: Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Black Children and Adolescents (R34 Clinical Trial Optional)
  Posted April 16, 2021, closed June 29, 2021
• PAS-21-216: Identification of Positive Valence System Related Targets for Novel Suicide Prevention Approaches (R01 - Clinical Trial Optional)
  Posted April 16, 2021, closed October 5, 2021
• PAR-21-186: Enhancing NIDCD's Extramural Workforce Diversity through Research Experiences (R25 Clinical Trial Not Allowed)
  Posted April 15, 2021, closed March 13, 2025
• RFA-HD-22-018: Biomarker Research to Support Fertility Regulation Development by Small Business (R43 Clinical Trial Optional)
  Posted April 15, 2021, closed July 29, 2021
• RFA-MD-21-008: NIMHD Multiple Chronic Disease Disparities Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed)
  Posted April 14, 2021, closed June 11, 2021
• RFA-MD-21-007: Centers for Multiple Chronic Diseases Associated with Health Disparities: Prevention, Treatment, and Management (P50 Clinical Trial Required)
  Posted April 14, 2021, closed June 24, 2021
• RFA-CA-21-037: 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)
  Posted April 14, 2021, closed November 22, 2021
• RFA-HD-22-014: Coordinating Center for the NICHD Population Dynamics Centers Research Infrastructure Program FY 2022 (R24 Clinical Trial Not Allowed)
  Posted April 13, 2021, closed July 29, 2021
• RFA-HD-22-013: Population Dynamics Centers Research Infrastructure Program FY 2022 (P2C Clinical Trial Not Allowed)
  Posted April 13, 2021, closed July 29, 2021
• RFA-OD-21-008: Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (U01 Clinical Trial Optional)
  Posted April 13, 2021, closed July 7, 2021
• RFA-OD-21-009: Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional)
  Posted April 13, 2021, closed July 7, 2021
• PAR-21-159: Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)
  Posted April 12, 2021, closed May 4, 2021
• PAR-21-152: NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)
  Posted April 8, 2021, closed April 23, 2021
• RFA-DA-22-019: Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R43/R44 - Clinical Trial Not Allowed)
  Posted April 8, 2021, closed August 10, 2021
• PAR-21-153: NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Clinical Trial Required)
  Posted April 8, 2021, closed May 7, 2024
• RFA-MH-21-180: BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access and Manipulation to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)
  Posted April 8, 2021, closed October 24, 2023
• RFA-DA-22-021: Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R41/R42 - Clinical Trial Not Allowed)
  Posted April 8, 2021, closed August 10, 2021
• RFA-AG-21-035: Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium Coordinating Center (U24 Clinical Trial Not Allowed)
  Posted April 8, 2021, closed June 9, 2021
• PAR-21-198: National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (T32)
  Posted April 8, 2021, closed September 27, 2023
• RFA-CA-21-029: Centers on Telehealth Research for Cancer-Related Care (P50 Clinical Trial Required)
  Posted April 8, 2021, closed July 20, 2021
• RFA-AI-21-013: Understanding HIV Reservoir Dynamics (P01, Clinical Trial Not Allowed)
  Posted April 7, 2021, closed July 30, 2021
• RFA-AI-21-018: Limited Interaction Targeted Epidemiology (LITE-2): To Advance HIV Prevention (UG3/UH3 Clinical Trial Optional)
  Posted April 7, 2021, closed August 4, 2021
• PAR-21-203: Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed)
  Posted April 6, 2021, closed March 1, 2022
• RFA-RM-21-015: NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
  Posted April 6, 2021, closed September 10, 2021
• PAR-21-213: Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed)
  Posted April 6, 2021, closed November 8, 2021
• RFA-HD-21-033: Community Engaged Research on Pregnancy Related and Associated Infections and Sepsis Morbidity and Mortality (UG3/UH3 Clinical Trial Optional)
  Posted April 6, 2021, closed May 20, 2021
• RFA-AG-22-016: Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R61/R33 Clinical Trial Required)
  Posted April 6, 2021, closed September 15, 2021
• PAR-21-207: Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Optional)
  Posted April 6, 2021, closed January 26, 2022
• RFA-DK-21-006: Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)
  Posted April 6, 2021, closed October 20, 2021
• RFA-CA-21-024: Proteogenomic Data Analysis Centers (PGDACs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed)
  Posted April 5, 2021, closed June 30, 2021
• RFA-CA-21-025: Proteogenomic Translational Research Centers (PTRCs) for Clinical Proteomic Tumor Analysis Consortium (U01 Clinical Trial Not Allowed)
  Posted April 5, 2021, closed July 30, 2021
• RFA-CA-21-023: Proteome Characterization Centers (PCCs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed)
  Posted April 5, 2021, closed June 30, 2021
• RFA-RM-21-020: Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed)
  Posted April 5, 2021, closed July 15, 2021
• RFA-DK-21-501: Limited Competition: Revision to the Longitudinal Monitoring of Pancreas Architecture in the Type 1 Diabetes in Acute Pancreatitis Consortium - Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional)
  Posted April 5, 2021, closed August 17, 2021
• PAR-21-188: Research Experiences to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)
  Posted April 5, 2021, closed March 13, 2025
• RFA-AA-21-005: Specialized Alcohol Research Centers (P50 Clinical Trial Optional)
  Posted April 5, 2021, closed November 15, 2021
• RFA-AA-21-006: Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)
  Posted April 5, 2021, closed November 15, 2021
• RFA-NS-21-013: BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed)
  Posted April 5, 2021, closed November 10, 2021
• RFA-NS-21-014: BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed)
  Posted April 5, 2021, closed November 10, 2021
• PAR-21-181: NINDS Program Project Grant (P01 Clinical Trial Optional)
  Posted April 5, 2021, closed May 7, 2024
• RFA-DA-22-002: Limited Competition Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)
  Posted April 2, 2021, closed May 26, 2021
• RFA-TR-21-015: Intramural - Extramural Collaboration for Drug Screening with Biofabricated 3-D Disease Tissue Models (UH2/UH3 Clinical Trial Not Allowed)
  Posted April 2, 2021, closed June 28, 2021
• RFA-AI-21-019: Radiation-Induced Immune Dysfunction (U01 Clinical Trial Not Allowed)
  Posted April 2, 2021, closed August 24, 2021
• PAR-21-185: Mentoring Networks to Enhance Diversity in NIDCD's Extramural Research Workforce (R25 Clinical Trial Not Allowed)
  Posted April 1, 2021, closed September 30, 2024
• PAR-21-211: Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required)
  Posted April 1, 2021, closed October 30, 2024
• PAR-21-210: Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
  Posted April 1, 2021, closed October 30, 2024
• RFA-RM-21-012: Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
  Posted April 1, 2021, closed July 15, 2021
• PAR-21-197: NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
  Posted April 1, 2021, closed September 7, 2021
• PA-21-214: Short-Term Mentored Research Career Enhancement Award to Promote Diversity (K18 No Independent Clinical Trials)
  Posted April 1, 2021, closed February 12, 2023
• RFA-AI-21-012: Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed)
  Posted March 31, 2021, closed August 4, 2021
• PAR-21-187: NIDCD's Mentoring Networks to Enhance Clinician-Scientists' Participation in Research (R25 Clinical Trial Not Allowed)
  Posted March 31, 2021, closed October 1, 2024
• PA-21-199: Research on Autism Spectrum Disorders (R03 Clinical Trial Optional)
  Posted March 31, 2021, closed November 16, 2024
• PA-21-200: Research on Autism Spectrum Disorders (R21 Clinical Trial Optional)
  Posted March 31, 2021, closed November 16, 2024
• PA-21-201: Research on Autism Spectrum Disorders (R01 Clinical Trial Optional)
  Posted March 31, 2021, closed January 25, 2025
• RFA-HD-22-010: Technologies to Advance Precision Medicine for Reproductive Health and Infertility (R43, R44 Clinical Trial Optional)
  Posted March 31, 2021, closed July 29, 2021
• RFA-AR-21-015: Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases, and Sjgrens Syndrome (UC2 Clinical Trial Optional)
  Posted March 31, 2021, closed July 15, 2021
• RFA-AR-21-016: Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2 Clinical Trial Not Allowed)
  Posted March 31, 2021, closed July 15, 2021
• PAR-21-196: Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)
  Posted March 31, 2021, closed October 13, 2023
• RFA-AI-21-009: Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed)
  Posted March 30, 2021, closed July 30, 2021
• RFA-AI-21-023: Respond: Epidemiology to End the HIV Epidemic (RESPOND: EEE) (R01 Clinical Trial Optional)
  Posted March 30, 2021, closed July 30, 2021
• RFA-HG-21-007: Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial Not Allowed)
  Posted March 30, 2021, closed February 1, 2023
• RFA-AI-21-024: Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01 Clinical Trial Optional)
  Posted March 30, 2021, closed August 4, 2021
• RFA-AI-21-025: Prevention Strategies to End the HIV Epidemic (R01 Clinical Trial Optional)
  Posted March 30, 2021, closed July 30, 2021
• RFA-HG-21-006: Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial Not Allowed)
  Posted March 30, 2021, closed February 1, 2023
• RFA-HG-21-008: Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)
  Posted March 30, 2021, closed February 1, 2023
• RFA-HD-22-019: User-Based Design to Aid in Contraceptive Development by Small Business (R43 Clinical Trial Not Allowed)
  Posted March 29, 2021, closed July 29, 2021
• RFA-DK-21-015: Nutrition Obesity Research Centers (P30 Clinical Trial Optional)
  Posted March 29, 2021, closed October 20, 2021
• PAR-21-162: Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
  Posted March 29, 2021, closed April 23, 2021
• PAR-21-208: Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
  Posted March 26, 2021, closed August 14, 2024
• RFA-TW-21-002: Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research Training (Collaborative U2R Clinical Trial Optional)
  Posted March 26, 2021, closed July 8, 2021
• RFA-TW-21-001: Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research (Collaborative U01 Clinical Trial Optional)
  Posted March 26, 2021, closed July 8, 2021
• RFA-CA-21-036: SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
  Posted March 25, 2021, closed August 6, 2021
• PAR-21-143: NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00)
  Posted March 25, 2021, closed December 3, 2024
• PAR-21-166: Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
  Posted March 25, 2021, closed December 30, 2024
• PAR-21-206: Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
  Posted March 25, 2021, closed December 30, 2024
• RFA-RM-21-021: Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed)
  Posted March 25, 2021, closed May 28, 2021
• RFA-RM-21-022: Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed)
  Posted March 25, 2021, closed May 28, 2021
• RFA-LM-21-001: NLM Institutional Grants for Research Training in Biomedical Informatics and Data Science (T15 Clinical Trial Not Allowed)
  Posted March 24, 2021, closed May 14, 2021
• RFA-AG-22-009: Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Aging (R25 - Clinical Trial Not Allowed)
  Posted March 23, 2021, closed October 4, 2021
• RFA-AG-22-010: Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer's Disease and Related Dementias (R25 - Clinical Trial Not Allowed)
  Posted March 23, 2021, closed October 4, 2021
• PAR-21-183: Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)
  Posted March 23, 2021, closed December 6, 2023
• PAR-21-212: Limited Competition: Alzheimers Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed)
  Posted March 23, 2021, closed May 7, 2024
• RFA-MD-21-004: Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)
  Posted March 23, 2021, closed August 24, 2021
• RFA-AT-21-006: Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional)
  Posted March 23, 2021, closed July 14, 2021
• RFA-HD-22-006: Recompetition of the Pediatric Scientist Development Program (PSDP) (K12 Clinical Trial Not Allowed)
  Posted March 22, 2021, closed July 29, 2021
• RFA-AR-22-002: Core Centers for Clinical Research (CCCR) (P30)- Clinical Trial Not Allowed
  Posted March 19, 2021, closed September 13, 2021
• RFA-DK-20-034: Program to Advance the Career Development of Scientists from Diverse Backgrounds Conducting Nutrition, Obesity, Diabetes, and Related Research (U24 Clinical Trial Optional)
  Posted March 19, 2021, closed July 14, 2021
• RFA-AG-22-013: High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Optional)
  Posted March 18, 2021, closed June 23, 2021
• RFA-AG-22-012: High-Priority Behavioral and Social Research Networks in Alzheimers Disease and Alzheimers Disease-Related Dementias (R24 Clinical Trial Optional)
  Posted March 18, 2021, closed June 23, 2021
• PAR-21-184: Research on Bat Immunology (R21 Clinical Trial Not Allowed)
  Posted March 18, 2021, closed March 15, 2022
• PAR-21-175: Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional)
  Posted March 18, 2021, closed January 7, 2025
• PAR-21-176: Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional)
  Posted March 18, 2021, closed January 7, 2025
• PAR-21-061: Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
  Posted March 18, 2021, closed November 17, 2023
• PAR-21-169: Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
  Posted March 18, 2021, closed September 7, 2023
• PAR-21-173: Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
  Posted March 18, 2021, closed January 7, 2024
• PAR-21-167: Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
  Posted March 17, 2021, closed November 14, 2024
• RFA-AI-21-021: Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed)
  Posted March 17, 2021, closed January 18, 2022
• RFA-AI-21-035: Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed)
  Posted March 17, 2021, closed August 22, 2022
• RFA-DK-21-004: The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional)
  Posted March 17, 2021, closed March 9, 2022
• RFA-AI-21-020: Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)
  Posted March 17, 2021, closed August 22, 2022
• PA-21-194: Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed)
  Posted March 16, 2021, closed April 20, 2023
• PA-21-195: Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required)
  Posted March 16, 2021, closed April 20, 2023
• PAR-21-189: Medical Scientist Training Program (T32)
  Posted March 15, 2021, closed January 25, 2024
• PAR-21-171: Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Required)
  Posted March 15, 2021, closed April 18, 2023
• PAR-21-318: The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required)
  Posted March 15, 2021, closed March 14, 2024
• PAR-21-111: The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required)
  Posted March 15, 2021, closed March 14, 2024
• RFA-OD-21-005: Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 - Independent Clinical Trial Not Allowed)
  Posted March 15, 2021, closed June 4, 2021
• PAR-21-172: Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Not Allowed)
  Posted March 15, 2021, closed May 7, 2024
• PAR-21-170: Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Independent Basic Experimental Studies with Humans Required)
  Posted March 15, 2021, closed May 7, 2024
• PAR-21-128: The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)
  Posted March 15, 2021, closed March 14, 2024
• PAR-21-190: Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
  Posted March 12, 2021, closed March 7, 2024
• PAR-21-163: Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
  Posted March 11, 2021, closed August 19, 2024
• RFA-NS-21-015: HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)
  Posted March 11, 2021, closed April 22, 2022
• RFA-NS-21-016: HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (R34 Clinical Trial Not Allowed)
  Posted March 11, 2021, closed May 18, 2021
• RFA-MD-21-005: Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
  Posted March 11, 2021, closed May 3, 2021
• RFA-MD-21-006: Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
  Posted March 11, 2021, closed May 3, 2021
• PAR-21-123: Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
  Posted March 11, 2021, closed October 21, 2024
• PAR-21-124: Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
  Posted March 11, 2021, closed October 21, 2024
• PAR-21-122: Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
  Posted March 11, 2021, closed October 21, 2024
• RFA-OD-21-004: Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)
  Posted March 10, 2021, closed March 8, 2023
• RFA-OD-21-003: Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
  Posted March 10, 2021, closed March 8, 2023
• RFA-MH-21-135: BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
  Posted March 10, 2021, closed March 23, 2022
• RFA-MH-21-130: BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
  Posted March 10, 2021, closed October 7, 2021
• PAS-21-150: New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)
  Posted March 8, 2021, closed May 7, 2024
• RFA-MH-21-170: Limited Competition to Convert the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Study Cohort to a Research Resource (R24 - Clinical Trial Not Allowed)
  Posted March 8, 2021, closed May 10, 2021
• PAR-21-161: Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional)
  Posted March 5, 2021, closed April 22, 2021
• PAR-21-193: NIOSH Support for Conferences and Scientific Meetings (U13 Clinical Trial Not Allowed)
  Posted March 5, 2021, closed December 14, 2025
• RFA-AI-21-005: Tropical Medicine Research Centers Coordinating Center (U01 Clinical Trial Not Allowed)
  Posted March 5, 2021, closed June 18, 2021
• PAR-21-192: Firearm Injury and Mortality Prevention Research (R01Clinical Trial Optional)
  Posted March 5, 2021, closed April 30, 2021
• RFA-AI-21-004: Tropical Medicine Research Centers (U01 Clinical Trial Not Allowed)
  Posted March 5, 2021, closed June 18, 2021
• PAR-21-191: Firearm Injury and Mortality Prevention Research (R21/R33 Clinical Trial Optional)
  Posted March 5, 2021, closed April 30, 2021
• PAR-21-141: AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed)
  Posted March 4, 2021, closed September 7, 2023
• PAR-21-160: NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
  Posted March 4, 2021, closed January 8, 2025
• RFA-AG-22-020: Triadic Interactions in Clinical Encounters Involving People with Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD), Clinicians, and Care Partners (R01 Clinical Trial Optional)
  Posted March 2, 2021, closed June 23, 2021
• PAR-21-133: First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required)
  Posted March 2, 2021, closed October 15, 2024
• PAR-21-130: Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required)
  Posted March 2, 2021, closed October 15, 2024
• PAR-21-134: Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
  Posted March 2, 2021, closed October 15, 2024
• PAR-21-132: Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
  Posted March 2, 2021, closed October 15, 2024
• PAR-21-131: Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required)
  Posted March 2, 2021, closed October 15, 2024
• PAR-21-135: Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
  Posted March 2, 2021, closed October 15, 2024
• PAR-21-136: Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
  Posted March 2, 2021, closed October 15, 2024
• PAR-21-129: Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01 Clinical Trial Required)
  Posted March 2, 2021, closed February 15, 2024
• PAR-21-137: Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
  Posted March 2, 2021, closed October 15, 2024
• RFA-DA-22-010: Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional)
  Posted February 26, 2021, closed October 25, 2022
• PAR-21-156: The Midlife in the United States Study (U19 Clinical Trial Not Allowed)
  Posted February 26, 2021, closed February 1, 2022
• PAR-21-157: The Midlife in the United States Study - Cognitive and Neurocognitive Precursors of AD/ADRD (U01 Clinical Trial Not Allowed)
  Posted February 26, 2021, closed February 1, 2022
• RFA-HL-22-003: Lung Transplant Consortium - Data Coordinating Center (U24 - Clinical Trial Not Allowed)
  Posted February 25, 2021, closed June 15, 2021
• RFA-HL-22-002: Lung Transplant Consortium - Clinical Centers (U01 - Clinical Trial Not Allowed)
  Posted February 25, 2021, closed June 15, 2021
• RFA-DE-22-001: NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed)
  Posted February 24, 2021, closed July 26, 2021
• RFA-RM-21-019: NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed)
  Posted February 24, 2021, closed April 23, 2021
• PAR-21-149: NINDS Institutional Research Training Program (T32 - Clinical Trial Not Allowed)
  Posted February 24, 2021, closed May 25, 2023
• PAR-21-147: Maximizing Access to Research Careers (T34 - Clinical Trial Not Allowed)
  Posted February 23, 2021, closed May 26, 2023
• RFA-MH-21-120: Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional)
  Posted February 23, 2021, closed December 9, 2021
• RFA-HL-22-007: Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Clinical Centers (Collaborative UG3/UH3 Clinical Trial Required)
  Posted February 22, 2021, closed June 11, 2021
• RFA-HL-22-008: Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center (U24 Clinical Trial Required)
  Posted February 22, 2021, closed June 11, 2021
• RFA-AI-21-007: Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33 Clinical Trial Not Allowed)
  Posted February 19, 2021, closed June 30, 2021
• RFA-AI-21-022: Limited Competition: Facility and Building System Upgrades Support for the Regional Biocontainment Laboratories (G20 Clinical Trial Not Allowed)
  Posted February 19, 2021, closed April 16, 2021
• RFA-CA-21-030: Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)
  Posted February 19, 2021, closed June 2, 2021
• RFA-DK-21-005: Immune Cell Engineering For Targeted Therapy And Disease Monitoring in Type 1 Diabetes (R01 Clinical Trial Not Allowed)
  Posted February 19, 2021, closed June 22, 2021
• PAR-21-146: Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34 - Clinical Trial Not Allowed)
  Posted February 18, 2021, closed May 26, 2023
• RFA-OD-21-002: Tobacco Regulatory Science (R01 Clinical Trial Optional)
  Posted February 17, 2021, closed February 14, 2023
• RFA-TW-21-003: Fogarty Global Trauma and Injury Research Training Program (D43 Clinical Trial Optional)
  Posted February 17, 2021, closed April 16, 2021
• PAR-21-120: Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
  Posted February 17, 2021, closed August 3, 2023
• RFA-AI-21-006: Basic Research to Inform Vaccine and Therapeutic Development for Non-Polio Human Enteroviruses (NPEV) (R01 Clinical Trial Not Allowed)
  Posted February 12, 2021, closed July 13, 2021
• PA-21-151: NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
  Posted February 10, 2021, closed January 7, 2024
• PAR-20-319: NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional)
  Posted February 9, 2021, closed October 14, 2022
• PAR-21-126: High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
  Posted February 8, 2021, closed June 15, 2021
• RFA-RM-21-011: Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed)
  Posted February 8, 2021, closed June 18, 2021
• PAR-21-060: NIDCR Predoctoral to Postdoctoral Transition Award for a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed)
  Posted February 8, 2021, closed January 7, 2024
• PAR-21-115: Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
  Posted February 8, 2021, closed November 5, 2024
• PAR-21-125: Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
  Posted February 8, 2021, closed June 15, 2021
• PAR-21-127: Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
  Posted February 8, 2021, closed June 15, 2021
• RFA-AI-20-079: Human Immunology Project Consortium (U19 Clinical Trial Optional)
  Posted February 8, 2021, closed June 4, 2021
• RFA-AI-20-080: Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed)
  Posted February 8, 2021, closed June 4, 2021
• RFA-AA-21-002: SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)
  Posted February 5, 2021, closed August 17, 2021
• RFA-AA-21-004: SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)
  Posted February 5, 2021, closed August 17, 2021
• RFA-AA-21-003: SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)
  Posted February 5, 2021, closed August 17, 2021
• RFA-DA-22-006: High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 - Clinical Trials Not Allowed)
  Posted February 4, 2021, closed September 15, 2021
• RFA-TR-21-009: Screening for Conditions by Electronic Nose Technology (SCENT) (U01 Clinical Trial Optional)
  Posted February 3, 2021, closed June 10, 2021
• RFA-AG-22-011: Early-Phase Clinical Trials of Novel Interventions to Prevent, Delay, or Treat Aging-Related Conditions by Targeting Aging-Related Mechanisms (U01 Clinical Trial Required)
  Posted February 3, 2021, closed June 17, 2021
• RFA-DA-22-004: Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)
  Posted February 2, 2021, closed August 10, 2022
• PAR-21-116: Limited Competition for the Continuation of Multisite Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Optional)
  Posted February 1, 2021, closed September 27, 2023
• PAR-21-117: Limited Competition for the Continuation or Revision of Multisite Clinical Trial Clinical Coordinating Center (Collaborative UH3 Clinical Trial Optional)
  Posted February 1, 2021, closed September 27, 2023
• PAR-21-144: Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required)
  Posted February 1, 2021, closed March 17, 2021
• PAR-21-145: Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed)
  Posted February 1, 2021, closed March 17, 2021
• RFA-AG-22-008: The Cellular Scale Connectome in Aging and Alzheimers Disease (U01 Clinical Trial Not Allowed)
  Posted January 29, 2021, closed June 15, 2021
• PAR-20-317: NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed)
  Posted January 26, 2021, closed May 25, 2023
• PAR-21-114: NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)
  Posted January 25, 2021, closed April 5, 2024
• PAR-21-106: NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
  Posted January 25, 2021, closed May 7, 2024
• RFA-DA-22-008: NIH Blueprint for Neuroscience Research: Tools and Technologies to Explore Nervous System Biomolecular Condensates (R21 Clinical Trial Not Allowed)
  Posted January 25, 2021, closed September 15, 2021
• PAR-21-112: Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32)
  Posted January 22, 2021, closed September 25, 2023
• RFA-RM-21-004: Nutrition for Precision Health, powered by the All of Us Research Program: Dietary Assessment Center (U24 Clinical Trial Optional)
  Posted January 21, 2021, closed April 6, 2021
• RFA-RM-21-002: Nutrition for Precision Health, powered by the All of Us Research Program: Metabolomics and Clinical Assays Center (U24 Clinical Trial Not Allowed)
  Posted January 21, 2021, closed April 6, 2021
• RFA-RM-21-005: Nutrition for Precision Health, powered by the All of Us Research Program: Clinical Centers (UG1 Clinical Trial Required)
  Posted January 21, 2021, closed April 6, 2021
• RFA-RM-21-001: Nutrition for Precision Health, powered by the All of Us Research Program: Artificial Intelligence for Multimodal Data Modeling and Bioinformatics Center (U54 Clinical Trial Not Allowed)
  Posted January 21, 2021, closed April 6, 2021
• RFA-RM-21-003: Nutrition for Precision Health, powered by the All of Us Research Program: Microbiome and Metagenomics Center (U24 Clinical Trial Not Allowed)
  Posted January 21, 2021, closed April 6, 2021
• RFA-RM-21-006: Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center (U24 Clinical Trial Not Allowed)
  Posted January 21, 2021, closed April 6, 2021
• PAR-21-096: NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required)
  Posted January 19, 2021, closed January 7, 2024
• PAR-21-139: Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
  Posted January 19, 2021, closed March 17, 2021
• PAR-21-094: NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Required)
  Posted January 19, 2021, closed January 7, 2024
• PAR-21-095: NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Clinical Trial Not Allowed)
  Posted January 19, 2021, closed January 7, 2024
• PAR-21-118: NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required)
  Posted January 15, 2021, closed January 7, 2024
• RFA-AG-21-034: Infectious Etiology of Alzheimer's Disease (R01 Clinical Trial Optional)
  Posted January 15, 2021, closed March 31, 2021
• PAR-21-119: NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required)
  Posted January 15, 2021, closed January 7, 2024
• RFA-EY-21-001: BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
  Posted January 15, 2021, closed September 21, 2023
• RFA-TR-21-008: Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional)
  Posted January 15, 2021, closed April 19, 2021
• PAR-21-108: NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed)
  Posted January 14, 2021, closed January 7, 2024
• PAR-21-082: NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
  Posted January 14, 2021, closed January 13, 2024
• PAR-21-083: NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
  Posted January 14, 2021, closed January 13, 2024
• RFA-DK-21-001: Biomarkers for Diabetic Foot Ulcers through the Diabetic Foot Consortium (R61/R33 Clinical Trial Not Allowed)
  Posted January 13, 2021, closed November 3, 2021
• PA-21-110: Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)
  Posted January 13, 2021, closed January 7, 2024
• RFA-TR-21-010: Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)
  Posted January 13, 2021, closed January 12, 2022
• RFA-AI-20-078: Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)
  Posted January 12, 2021, closed June 18, 2021
• RFA-AI-20-077: Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed)
  Posted January 12, 2021, closed June 18, 2021
• RFA-HD-21-032: HEAL Initiative: Data Coordinating Center for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (U24 Clinical Trial Required)
  Posted January 11, 2021, closed March 30, 2021
• RFA-DA-21-020: HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed)
  Posted January 11, 2021, closed March 31, 2021
• RFA-DA-21-021: HEAL Initiative: HEALthy Brain and Child Development Study (U01 - Clinical Trial Not Allowed)
  Posted January 11, 2021, closed March 31, 2021
• RFA-MH-21-145: HEAL Initiative: Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional)
  Posted January 11, 2021, closed March 18, 2021
• RFA-HD-21-031: HEAL Initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial - Clinical Sites (UG1 Clinical Trial Required)
  Posted January 11, 2021, closed March 30, 2021
• RFA-DA-21-022: HEAL Initiative: HEALthy Brain and Child Development Consortium Administrative Core (U24 - Clinical Trial Not Allowed)
  Posted January 11, 2021, closed March 31, 2021
• RFA-DA-21-023: HEAL Initiative: HEALthy Brain and Child Development Data Coordinating Center (U24)
  Posted January 11, 2021, closed March 31, 2021
• PAR-21-109: Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
  Posted January 11, 2021, closed May 7, 2024
• RFA-DA-21-029: HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Coordination and Dissemination Center (R24 Clinical Trial Optional)
  Posted January 11, 2021, closed March 26, 2021
• RFA-DA-21-030: HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)
  Posted January 11, 2021, closed March 26, 2021
• PAR-21-062: Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of the NIDDK (R21 Clinical Trial Not Allowed)
  Posted January 11, 2021, closed January 7, 2024
• RFA-AG-21-033: Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed)
  Posted January 8, 2021, closed March 18, 2021
• PAS-21-031: Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional)
  Posted January 8, 2021, closed January 7, 2024
• PAR-21-089: Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed)
  Posted January 8, 2021, closed January 7, 2024
• RFA-DK-20-508: Limited Competition: Revision to the Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
  Posted January 7, 2021, closed April 14, 2021
• RFA-AI-21-001: Tuberculosis Research Advancement Centers (P30 Clinical Trials Not Allowed)
  Posted January 7, 2021, closed June 15, 2021
• RFA-HL-21-014: Understanding and Reducing Cardiovascular Disease in Type 1 Diabetes Mellitus (R01 Clinical Trial Optional)
  Posted January 6, 2021, closed October 15, 2021
• RFA-DK-20-032: Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required)
  Posted January 6, 2021, closed June 22, 2023
• RFA-NS-21-017: Next Generation Sequencing in Post Mortem Tissue from Patients with Parkinsons Disease (U01 Clinical Trial Not Allowed)
  Posted January 6, 2021, closed March 15, 2021
• RFA-RM-21-008: Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed)
  Posted January 6, 2021, closed March 22, 2021
• RFA-RM-21-009: Cellular Senescence Network: Technology Development and Application (UG3/UH3 Clinical Trial Not Allowed)
  Posted January 6, 2021, closed March 22, 2021
• RFA-RM-21-010: Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed)
  Posted January 6, 2021, closed March 22, 2021
• PAR-21-104: International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed
  Posted January 4, 2021, closed March 8, 2023
• PAR-21-105: International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required)
  Posted January 4, 2021, closed March 8, 2023
• PAR-21-121: Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
  Posted January 4, 2021, closed October 17, 2023
• RFA-AG-22-006: New Approaches to Identify Neurogenesis and Study its Dynamics in Brain Aging and AD/ADRD (R01 Clinical Trial Not Allowed)
  Posted January 4, 2021, closed June 17, 2021

Other years: 2026 (65), 2025 (75), 2024 (609), 2023 (720), 2022 (735).